|View printer-friendly version|
|February 22, 2010 2:42 p.m.|
|Teva To Present At The 14th Annual Israeli Equities Conference|
|Jersulaem, Israel, February 22, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 14th Annual Israeli Equities Conference with Eyal Desheh, Chief Financial Officer, presenting on Wednesday, February 24, 2010.|
What: Teva Presentation at the 14th Annual Israeli Equities Conference
Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.
When: Wednesday, February 24, 2010 at 2:30 p.m. ET
Where: http://www.veracast.com/webcasts/opco/nasdaq2010/31209136.cfm or http://www.tevapharm.com/financial/
How: Live over the Internet -- log onto the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.
Company Contacts:Elana Holzman
Teva Pharmaceutical Industries Ltd.
972 (3) 926-7554
Teva North America